WALTHAM, Mass.--(BUSINESS WIRE)--
NeuroMetrix, Inc. (Nasdaq:NURO) reported that its President and Chief
Executive Officer, Shai N. Gozani, M.D., Ph.D., provided an update and
overview of company business activities on January 14, 2015 at
the Biotech Showcase 2015 conference in San Francisco. Dr. Gozani's
discussion particularly focused on Quell™, the company's newly unveiled
wearable technology for relief of chronic pain. The presentation is
archived and may be accessed for 90 days at http://edge.media-server.com/m/p/audrhjcw.
The corporate presentation used by Dr. Gozani is available at www.NeuroMetrix.com
under the "Investor Relations" tab.
About NeuroMetrix
NeuroMetrix is an innovative health-care company that develops wearable
medical technology and point-of-care tests that help patients and
physicians better manage chronic pain, nerve diseases, and sleep
disorders. For more information, please visit http://www.NeuroMetrix.com.
NeuroMetrix, Inc.
Thomas T. Higgins, 781-314-2761
SVP and
Chief Financial Officer
neurometrix.ir@neurometrix.com
Source: NeuroMetrix, Inc.
News Provided by Acquire Media
